Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | Dec. 31 |
Director of Finance/CFO | - | 23-04-02 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Luc Burgard
COO | Chief Operating Officer | 43 | - |
Marc Funk
BRD | Director/Board Member | 64 | 20-12-31 |
Human Resources Officer | - | - | |
Kieran Chouhan
PRN | Corporate Officer/Principal | - | 19-01-31 |
Bernard Pluta
PRN | Corporate Officer/Principal | - | 15-09-30 |
Shabbir Mostafa
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | 15-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 21-02-28 |
Director/Board Member | 67 | 20-12-31 | |
Richard Ridinger
CHM | Chairman | 66 | 21-02-28 |
Marc Funk
BRD | Director/Board Member | 64 | 20-12-31 |
Director/Board Member | 43 | 21-02-28 | |
Henrik Giver
BRD | Director/Board Member | 35 | 20-12-31 |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 370,000 | 0 | 0 | 56.25 % |
Stock B | 10 | 21,312,000 | 0 | 0 | |
Stock C | 1 | 79,803,683 | 57,089,305 ( 71.54 %) | 0 |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. |
Pharmaceuticals: Major
|
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. |
Miscellaneous
|
Recipharm Venture Fund AB
Recipharm Venture Fund AB Investment ManagersFinance Recipharm Venture Fund AB is a venture capital fund that makes strategic investments in start-ups and biotechnology companies that are seen as important to Recipharm's business. The fund invests in both private and public companies. |
Investment Managers
|
Sector
1st Jan change | Capi. | |
---|---|---|
+13.52% | 9.63B | |
-7.87% | 5.37B | |
+12.50% | 4.28B | |
+18.09% | 3.71B | |
+42.95% | 2.91B | |
-19.01% | 2.54B | |
-20.66% | 2.37B | |
+17.86% | 1.87B | |
-0.50% | 1.64B |